Пређи на садржај

BMY-14802

С Википедије, слободне енциклопедије
BMY-14802
IUPAC ime
1-(4-fluorophenyl)-4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]butan-1-ol
Identifikatori
CAS broj105565-55-7 Зелена квачицаДа
ATC kodnone
PubChemCID 108046
Hemijski podaci
FormulaC18H22F2N4O
Molarna masa348.389 g/mol
  • c1cc(F)ccc1C(O)CCCN2CCN(CC2)c3ncc(F)cn3

BMY-14802 je lek sa antipsihotičkim dejstvom. On je antagonist sigma receptora, i agonist 5-HT1A receptora.[1][2][3][4]

  1. ^ Taylor DP, Eison MS, Moon SL, Schlemmer RF, Shukla UA, VanderMaelen CP, Yocca FD, Gallant DJ, Behling SH, Boissard CG (1993). . „A role for sigma binding in the antipsychotic profile of BMY 14802?”. NIDA Research Monograph. 133: 125—57. PMID 8232511. 
  2. ^ Vanecek SA, Essman WD, Taylor DP, Woods JH (1998). . „Discriminative stimulus characteristics of BMY 14802 in the pigeon”. The Journal of Pharmacology and Experimental Therapeutics. 284 (1): 1—9. PMID 9435153. 
  3. ^ Kitanaka J, Kitanaka N, Tatsuta T, Hall FS, Uhl GR, Tanaka K, Nishiyama N, Morita Y, Takemura M (2009). . „Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice”. Psychopharmacology. 203 (4): 781—92. PMID 19052726. doi:10.1007/s00213-008-1425-z. 
  4. ^ Paquette MA, Foley K, Brudney EG, Meshul CK, Johnson SW, Berger SP (2009). . „The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism”. Psychopharmacology. 204 (4): 743—54. PMC 2845289Слободан приступ. PMID 19283364. doi:10.1007/s00213-009-1505-8. 


Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).